Avalo Therapeutics, Inc.
AVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534120
In the last 90 days, Avalo Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $1.31B in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Avalo Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 21 | 1 | 29 | +9 |
| Shares | 771.1K | 329 | 6.66M | +5.89M (+763.7%) |
| Value | $9.62M | $4.10K | $63.2M | +$53.6M (+557.6%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Avalo Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| OrbiMed Advisors LLC | 967,000 | $9.19M | 0.17% |
| Ra Capital Management, L.P. | 967,000 | $9.19M | 0.11% |
| Deep Track Capital, LP | 967,000 | $9.19M | 0.29% |
| BVF Inc | 967,000 | $9.15M | 0.27% |
| TCG Crossover Management, LLC | 483,000 | $4.59M | 0.39% |
| Boothbay Fund Management, LLC | 164,092 | $1.56M | 0.05% |
| Geode Capital Management, LLC | 10,111 | $95.6K | 0.00% |
| Tower Research Capital LLC (TRC) | 376 | $3.57K | 0.00% |
| BlackRock, Inc. | 329 | $3.13K | 0.00% |
| Jaffetilchin Investment Partners, LLC | 1 | $10 | 0.00% |
| Avion Wealth | 5 | $0 | 0.00% |
Sold out (2)
Institutions that held Avalo Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Royal Bank of Canada | 590 | $7.00K |
| Banque Cantonale Vaudoise | 338 | $4.00K |
Not filed for Q3 2024 yet (1)
Institutions that held Avalo Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 329 | $4.10K |